User Fee Talks Near the Wire As FDA, Industry Butt Heads

Devices & Diagnostics Letter
Devicemakers and the FDA remain divided on the terms of Medical Device User Fee and Modernization Act (MDUFMA) reauthorization as the deadline approaches for resolving differences.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00